Are drug-eluting stents safe?: Definitely! Or probably... possibly? Or maybe not yet....
Nakazawa
G
G
CV Path Institute, Gaithersburg, Maryland, USA.
Ladich
E
E
Virmani
R
R
D000497:Alloys; D002317:Cardiovascular Agents / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D023903:Coronary Restenosis / Q000517:prevention & control*; D054855:Drug-Eluting Stents / Q000009:adverse effects*; D006801:Humans; D006967:Hypersensitivity / Q000209:etiology*; D015994:Incidence; D017239:Paclitaxel / Q000009:adverse effects; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012307:Risk Factors; D020123:Sirolimus / Q000009:adverse effects; D013927:Thrombosis / Q000209:etiology* / Q000517:prevention & control; D013997:Time Factors
D000497:Alloys; D002317:Cardiovascular Agents; D010975:Platelet Aggregation Inhibitors; D017239:Paclitaxel; D020123:Sirolimus